Literature DB >> 22431596

Structure of a hepatitis C virus RNA domain in complex with a translation inhibitor reveals a binding mode reminiscent of riboswitches.

Sergey M Dibrov1, Kejia Ding, Nicholas D Brunn, Matthew A Parker, B Mikael Bergdahl, David L Wyles, Thomas Hermann.   

Abstract

The internal ribosome entry site (IRES) in the hepatitis C virus (HCV) RNA genome is essential for the initiation of viral protein synthesis. IRES domains adopt well-defined folds that are potential targets for antiviral translation inhibitors. We have determined the three-dimensional structure of the IRES subdomain IIa in complex with a benzimidazole translation inhibitor at 2.2 Å resolution. Comparison to the structure of the unbound RNA in conjunction with studies of inhibitor binding to the target in solution demonstrate that the RNA undergoes a dramatic ligand-induced conformational adaptation to form a deep pocket that resembles the substrate binding sites in riboswitches. The presence of a well-defined ligand-binding pocket within the highly conserved IRES subdomain IIa holds promise for the development of unique anti-HCV drugs with a high barrier to resistance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22431596      PMCID: PMC3325719          DOI: 10.1073/pnas.1118699109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  AANT: the Amino Acid-Nucleotide Interaction Database.

Authors:  Michael M Hoffman; Maksim A Khrapov; J Colin Cox; Jianchao Yao; Lingnan Tong; Andrew D Ellington
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

2.  The pathway of HCV IRES-mediated translation initiation.

Authors:  Geoff A Otto; Joseph D Puglisi
Journal:  Cell       Date:  2004-10-29       Impact factor: 41.582

Review 3.  Determination of riboswitch structures: light at the end of the tunnel?

Authors:  Alexander Serganov
Journal:  RNA Biol       Date:  2010-01-25       Impact factor: 4.652

4.  Preexisting drug-resistance mutations reveal unique barriers to resistance for distinct antivirals.

Authors:  Margaret Robinson; Yang Tian; William E Delaney; Andrew E Greenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-06       Impact factor: 11.205

Review 5.  Hepatitis C viral protein translation: mechanisms and implications in developing antivirals.

Authors:  Brett Hoffman; Qiang Liu
Journal:  Liver Int       Date:  2011-05-05       Impact factor: 5.828

6.  A modular approach to synthetic RNA binders of the hepatitis C virus internal ribosome entry site.

Authors:  Maia Carnevali; Jerod Parsons; David L Wyles; Thomas Hermann
Journal:  Chembiochem       Date:  2010-07-05       Impact factor: 3.164

Review 7.  Ribozymes and riboswitches: modulation of RNA function by small molecules.

Authors:  Jinwei Zhang; Matthew W Lau; Adrian R Ferré-D'Amaré
Journal:  Biochemistry       Date:  2010-11-02       Impact factor: 3.162

8.  Ribosomal protein S5 interacts with the internal ribosomal entry site of hepatitis C virus.

Authors:  S Fukushi; M Okada; J Stahl; T Kageyama; F B Hoshino; K Katayama
Journal:  J Biol Chem       Date:  2001-04-30       Impact factor: 5.157

9.  An efficient new route to dihydropyranobenzimidazole inhibitors of HCV replication.

Authors:  Matthew A Parker; Emily Satkiewicz; Thomas Hermann; B Mikael Bergdahl
Journal:  Molecules       Date:  2010-12-30       Impact factor: 4.411

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  52 in total

1.  Aryl-substituted aminobenzimidazoles targeting the hepatitis C virus internal ribosome entry site.

Authors:  Kejia Ding; Annie Wang; Mark A Boerneke; Sergey M Dibrov; Thomas Hermann
Journal:  Bioorg Med Chem Lett       Date:  2014-05-14       Impact factor: 2.823

2.  Crystal-Structure-Guided Design of Self-Assembling RNA Nanotriangles.

Authors:  Mark A Boerneke; Sergey M Dibrov; Thomas Hermann
Journal:  Angew Chem Int Ed Engl       Date:  2016-02-23       Impact factor: 15.336

Review 3.  Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery.

Authors:  Sai Shashank Chavali; Rachel Bonn-Breach; Joseph E Wedekind
Journal:  J Biol Chem       Date:  2019-05-12       Impact factor: 5.157

Review 4.  Understanding the Contributions of Conformational Changes, Thermodynamics, and Kinetics of RNA-Small Molecule Interactions.

Authors:  Aline Umuhire Juru; Neeraj N Patwardhan; Amanda E Hargrove
Journal:  ACS Chem Biol       Date:  2019-05-01       Impact factor: 5.100

5.  Functional conservation despite structural divergence in ligand-responsive RNA switches.

Authors:  Mark A Boerneke; Sergey M Dibrov; Jing Gu; David L Wyles; Thomas Hermann
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-27       Impact factor: 11.205

6.  Small molecule-RNA targeting: starting with the fundamentals.

Authors:  Amanda E Hargrove
Journal:  Chem Commun (Camb)       Date:  2020-11-26       Impact factor: 6.222

Review 7.  Functional RNA structures throughout the Hepatitis C Virus genome.

Authors:  Rebecca L Adams; Nathan Pirakitikulr; Anna Marie Pyle
Journal:  Curr Opin Virol       Date:  2017-05-13       Impact factor: 7.090

8.  Conformational flexibility of viral RNA switches studied by FRET.

Authors:  Mark A Boerneke; Thomas Hermann
Journal:  Methods       Date:  2015-09-14       Impact factor: 3.608

9.  2-Aminobenzoxazole ligands of the hepatitis C virus internal ribosome entry site.

Authors:  Kevin D Rynearson; Brian Charrette; Christopher Gabriel; Jesus Moreno; Mark A Boerneke; Sergey M Dibrov; Thomas Hermann
Journal:  Bioorg Med Chem Lett       Date:  2014-06-04       Impact factor: 2.823

10.  Ligand-responsive RNA mechanical switches.

Authors:  Mark A Boerneke; Thomas Hermann
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.